Abstract:The purpose of this study was to investigate the role of the Zn finger protein CTCF in the establishment of genetic borders and in controlling spatially-restricted activity of a mammary-specific super-enhancer (SE) known to selectively activate gene expression during pregnancy. CRISPR/Cas9 gene editing was used to generate mice with deletions in CTCF binding sites (CBSs) separating the Wap SE from the Ramp3 gene. ChIP-seq and qRT-PCR were used to investigate protein-DNA interactions and changes in gene expression, respectively. RNA-seq data demonstrated that expression of the mammary-specific Wap and widely-expressed Ramp3 gene was activated in mammary tissue at the onset of lactation. To investigate the possibility that the Wap SE can regulate both genes, mice carrying deletions in the SE were established. In these mice, both Wap and downstream Ramp3 were downregulated to the same extent, supporting the notion that the SE regulates both genes. Given these results, we investigated the contributions of several intervening CBSs in dampening SE activity on Ramp3. Mice harboring individual and combinatorial deletions of three CBSs (A, B and C) between the Wap SE and Ramp3 were generated. While loss of CTCF at site B (ΔB) had no apparent effect, loss of site A (ΔA) led to an expansion of H3K27ac from the adjacent SE in mammary tissue. The site C mutation (ΔC) resulted in a two-fold induction of Ramp3 in mammary tissue. Mice lacking all three binding sites demonstrated a marked increase in Ramp3 expression, which indicates that the CBSs block expression in an additive manner. To test the possible insulator function of these in a tissue with opposing gene expression, cerebellum was chosen as Ramp3 is actively transcribed while Wap is silent. The ΔA and ΔB mice showed no phenotype, but surprisingly ΔC mice demonstrated an 80% reduction in Ramp3 expression. Analysis of ChIP-seq and DNAse-seq demonstrated that site C coincides with a cerebellum-specific enhancer, which appears to regulate Ramp3 expression. These data demonstrate that a SE can activate two genes, albeit to different degrees. Furthermore, we demonstrate that CBSs do not serve as tight genetic boundaries encapsulating transcriptional enhancers and their associated genes, but are porous borders that allow for fine tuning of transcriptional activity. Individual CBSs have a modest ability to insulate genes, but a cluster of CTCF proteins is required to adjust the enhancer activity on genes and prevent deregulation. In addition, we show that CBSs are not restricted to a unique function and can act in a tissue-specific manner to contribute to gene regulation. These data help us to develop a more nuanced understanding of SE function as well as the roles of CTCF in regulating gene expression. Previous studies have shown that SEs and CBSs are mutational hotspots in cancer, implicating them in tumorigenesis. A more complete understanding of their biology will allow a better understanding of their role in cancer. Citation Format: Michaela Willi, Tyler M. Kuhns, Kyung Hyun Yoo, Fabian Reinisch, Christian Reinbold, Teresa Mohr, Chaochen Wang, Lothar Hennighausen. The role of super-enhancers and genetic boundaries in gene regulation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4993. doi:10.1158/1538-7445.AM2017-4993

A promoter-dependent upstream activator augments CFTR expression in diverse epithelial cell types

Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator

Functional Assessment of CTCF Sites at Cytokine-Sensing Mammary Enhancers Using CRISPR/Cas9 Gene Editing in Mice.

The Role Of Super-Enhancers And Genetic Boundaries In Gene Regulation

Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway

Krüppel-Like Factor 5 Regulates CFTR Expression Through Repression by Maintaining Chromatin Architecture Coupled with Direct Enhancer Activation

The impact of genomic distance on enhancer‐promoter interactions at the CFTR locus

Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy

Specific multivalent molecules boost CRISPR-mediated transcriptional activation

Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation

Novel gain-of-function mutants identify a critical region within CFTR membrane-spanning domain 2 controlling cAMP-dependent and ATP-independent channel activation

Investigating Adverse Genomic and Regulatory Changes Caused by Replacement of the Full-length CFTR cDNA Using Cas9 and AAV

Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and C/EBP ? and identification of a downstream repressor

Pseudohalide anions reveal a novel extracellular site for potentiators to increase CFTR function

Spliceosome-Mediated Rna Trans-Splicing with Recombinant Adeno-Associated Virus Partially Restores Cystic Fibrosis Transmembrane Conductance Regulator Function to Polarized Human Cystic Fibrosis Airway Epithelial Cells

The Inhibition of the Membrane-Bound Transcription Factor Site-1 Protease (MBTP1) Alleviates the p.Phe508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Defects in Cystic Fibrosis Cells

In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis

CHD6 regulates the topological arrangement of the CFTR locus.

Gene Activation by a CRISPR-assisted Trans Enhancer

CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation

Structural determinants for transcriptional activation by cAMP-responsive DNA elements.